The session will take place on 10 June 2026, from 13:00 to 14:00, and will be led by Dr Kelly Kohut.

By bringing patient experiences into the discussion, the session will provide valuable insights into how care, communication and clinical approaches can better respond to the needs of individuals and families affected by Lynch syndrome.

The prestigious interdisciplinary prize from the European Society for Radiotherapy and Oncology (ESTRO) honors outstanding research and significant contributions across disciplines within radiation oncology. The award highlights both the high quality of the research environment and the importance of interdisciplinary collaboration in the development of future cancer treatments.
This year, the prize was given to Heidi Lyng, head of the Clinical Radiation Biology group at the Institute for Cancer Research, for her work to understand the radiobiology of patient tumors and translate this knowledge into clinical practice.

Kushtrim Kryeziu, leader of the "Functional precision oncology" project group at the Department Molecular Oncology, is first author on a recent article in Cell Reports Medicine, entitled "Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity".
"This study is a milestone for our organoid lab," says Dr. Kushtrim Kryeziu, announcing the establishment of a living biobank comprising 213 patient-derived organoids from colorectal cancer liver metastases.
"Created in close collaboration with researchers at our department and various clinical departments at OUS, the study details an in-depth pharmacogenomic analysis of tumor heterogeneity."

During this year's annual innovation celebration, Inven2 brought forward researchers and innovations that demonstrate how research from the University of Oslo and Oslo University Hospital can be developed into solutions with significant value for patients, business and society. Three awards were presented during the celebration: the Innovation Award 2026, the Innovator of the Year and the Audience Award.
The Innovator of the Year 2026 award went to Professor Guro Elisabeth Lind, head of the Epigenetics Group at the Department of Molecular Oncology at the Institute for Cancer Research, Oslo University Hospital.

Recommended sites for current OUS research news:

From Oslo University Hospital, in Norwegian:
OUS Innsikt – ny forskning, innovasjon og behandling - channel for science communication
More news from OUS (oslo-universitetssykehus.no)

From UiO and centres of excellence (UiO/OUS):
News from the Inst. of Clinical Medicine, UiO
Research news - UiO
CanCell - Centre for Cancer Cell Reprogramming 
Cresco - Centre for Embryology and Healthy Development 
PRIMA - Precision Immunotherapy Alliance - Norwegian version
Hybrid Technology Hub - Centre for Organ on a Chip-Technology

Each year, the University of Oslo (UiO) honors outstanding achievements when the University Board presents awards for research, education, dissemination and innovation.
This year, Anne Simonsen will be awarded the Research Prize for her groundbreaking studies of autophagy. Through her research, Simonsen has played a key role in demonstrating that reduced autophagy is an important factor in ageing, as well as in neurodegenerative diseases and cancer. We congratulate Anne Simonsen on this well-deserved recognition. She will receive the Research Prize during UiO’s Annual Celebration in September.